Calmare Therapeutics (CTTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 01-2000 | 12-1999 | 09-1999 | 07-1999 | 06-1999 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | N/A | 100 | 900 | N/A | 210 |
| Marketable Securities | N/A | 6,150 | 4,620 | N/A | 2,990 |
| Receivables | N/A | 550 | 1,720 | N/A | 2,200 |
| Other current assets | 0 | 120 | 160 | 0 | 90 |
| TOTAL | $N/A | $6,920 | $7,400 | $N/A | $5,490 |
| Non-Current Assets | |||||
| Investments And Advances | 0 | 90 | 90 | 0 | 200 |
| Other Non-Current Assets | 0 | 1,270 | 1,300 | 0 | 1,340 |
| TOTAL | $N/A | $1,360 | $1,390 | $N/A | $1,540 |
| Total Assets | $N/A | $8,430 | $8,950 | $N/A | $7,190 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 0 | 50 | 110 | 0 | 170 |
| Accrued Expenses | N/A | 1,330 | 1,660 | N/A | 2,540 |
| TOTAL | $N/A | $1,380 | $1,770 | $N/A | $2,720 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $N/A | $1,380 | $1,770 | $N/A | $2,720 |
| Shareholders' Equity | |||||
| Common Shares | N/A | 60 | 60 | N/A | 60 |
| Retained earnings | N/A | -18,690 | -18,540 | N/A | -21,130 |
| Other shareholders' equity | 0 | -50 | 40 | 0 | -80 |
| TOTAL | $N/A | $7,040 | $7,180 | $N/A | $4,470 |
| Total Liabilities And Equity | $0 | $8,420 | $8,950 | $0 | $7,190 |